Hip and knee replacements are commonly performed because of arthritis pain. Learn alternative, conservative treatment options.
The Shenzhen, China-based biotech plans to launch a Phase I trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IN026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results